Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

Babic, Ilijana; Gorak, Ashleigh; Hughes, Jason; Engel, Martin; Sellers, Dominic; Else, Paul; Lufe, Luisa; Obeid, Anita-Louise; Osborne, Ashleigh; Le Mesurier, P; Pai, Nagesh; Huang, Xu-Feng; Green, Katrina

Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

https://hdl.handle.net/10779/uow.27746439

journal contribution

posted on 2024-11-15, 02:11 authored by Ilijana Babic, Ashleigh Gorak, Jason Hughes, Martin Engel, Dominic Sellers, Paul ElsePaul Else, Luisa Lufe, Anita-Louise Obeid, Ashleigh Osborne, P Le Mesurier, Nagesh PaiNagesh Pai, Xu-Feng HuangXu-Feng Huang, Katrina Green

abstract of poster that was presented at the 30th CINP World Congress of Neuropsychopharmacology, 3-5 July, Seoul, Republic of Korea.

History

Related Materials

1.
ISSN - Is published in 1461-1457

Citation

Babic, I., Gorak, A., Hughes, J., Engel, M., Sellers, D., Else, P., Lufe, L., Obeid, A. L., Osborne, A., Le Mesurier, P., Pai, N., Huang, X. F. & Weston-Green, K. (2016). Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment. International Journal of Neuropsychopharmacology, 19 (Suppl. 1), 55-55.

Language

English

RIS ID

109146

Journal title

The International Journal of Neuropsychopharmacology

Volume

19

Issue

Suppl_1

Pagination

55-55

Publisher website/DOI

https://doi.org/10.1093/ijnp/pyw041.426

Usage metrics

Keywords

health sciences

Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

History

Related Materials

Citation

Language

RIS ID

Journal title

Volume

Issue

Pagination

Publisher website/DOI

Usage metrics

Categories

Keywords

Licence

Exports